These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38504757)

  • 1. Electrical storm in a middle-aged man.
    Ahadzi D; Agyekum F; Doku A; Yakubu AS; Hoedofia G; Ayetey H
    Ghana Med J; 2023 Jun; 57(2):156-160. PubMed ID: 38504757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrical Storm in ICD Recipients with Arrhythmogenic Right Ventricular Cardiomyopathy.
    Yin K; Ding L; Hua W; Zhang S
    Pacing Clin Electrophysiol; 2017 Jun; 40(6):683-692. PubMed ID: 28261825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.
    Link MS; Laidlaw D; Polonsky B; Zareba W; McNitt S; Gear K; Marcus F; Estes NA
    J Am Coll Cardiol; 2014 Jul; 64(2):119-25. PubMed ID: 25011714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion.
    Honarbakhsh S; Protonotarios A; Monkhouse C; Hunter RJ; Elliott PM; Lambiase PD
    Europace; 2023 May; 25(5):. PubMed ID: 37213071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
    Al-Ghamdi B; Shafquat A; Mallawi Y
    Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
    Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
    Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
    Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
    Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
    Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
    Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
    Molitor N; Hofer D; Çimen T; Gasperetti A; Akdis D; Costa S; Jenni R; Breitenstein A; Wolber T; Winnik S; Fokstuen S; Fu G; Medeiros-Domingo A; Ruschitzka F; Brunckhorst C; Duru F; Saguner AM
    Heart; 2023 Jul; 109(15):1146-1152. PubMed ID: 36889907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of arrhythmogenic right ventricular cardiomyopathy in the era of implantable cardioverter-defibrillators and radiofrequency catheter ablation.
    Komura M; Suzuki J; Adachi S; Takahashi A; Otomo K; Nitta J; Nishizaki M; Obayashi T; Nogami A; Satoh Y; Okishige K; Hachiya H; Hirao K; Isobe M
    Int Heart J; 2010 Jan; 51(1):34-40. PubMed ID: 20145349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
    Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).
    Romero J; Grushko M; Briceño DF; Natale A; Di Biase L
    Curr Cardiol Rep; 2017 Sep; 19(9):82. PubMed ID: 28779285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) in a Special Operations Soldier: A Case Report.
    Osborne KC; Wenthe A; Mahowald M; Bridwell RE
    J Spec Oper Med; 2024 Jun; 24(2):82-84. PubMed ID: 38830309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.